Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Low Price/Cash Ratio Value Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Norm Demers who wrote (812)	7/12/2003 12:57:23 PM
From: MCsweet	Read Replies (1) \| Respond to of 1931

Recommended stocks I have thought about CPST for awhile. My main reservation with CPST has been that they have an uneconomic product that they are committed to developing, and I think it will take a long time before they become profitable (if ever). However, the burn is reasonable, and the upside is decent if some good news comes out. As for PCYC, I think the board recommended buying a basket of biotech stocks earlier --- DUSA, DCRN, etc. PCYC seems reasonable --- I own PCYC some already. However, I personally wouldn't be betting the farm on PCYC or any biotech right now, since I don't understand biotech fundamentals except that very few of these companies make money. It seems like most of the returns from here would be from speculators bidding up the price of the stock. For me these irrational speculator-based run-ups are icing on the cake and not the bread-and-butter that can be depended on for safely earning profits. However, perhaps someone else has a better understanding of these biotech companies and there future prospects and can justify them to me on a fundamentals basis. MC